Aodi Wu

Shihezi, 832003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 14 publications

Immunogenicity and post-challenge virological outcomes of a multivalent subunit vaccine in sheep challenged with cytopathic BVDV-1a.

Immunogenicity and post-challenge virological outcomes of a multivalent subunit vaccine in sheep challenged with cytopathic BVDV-1a.

Journal: Veterinary microbiology

Published: April 22, 2026

Design of a Multi-Epitope Vaccine Against Ovine Pasteurella multocida Using Immunoinformatics Strategies.

Design of a Multi-Epitope Vaccine Against Ovine Pasteurella multocida Using Immunoinformatics Strategies.

Journal: Microorganisms

Published: February 05, 2026

The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice.

The subunit vaccine of Lumpy skin disease virus elicits significant humoral and cell-mediated immune responses in mice.

Journal: Frontiers in veterinary science

Published: October 24, 2025

Nanobodies Targeting the GP4 Protein Inhibit PRRSV Replication.

Nanobodies Targeting the GP4 Protein Inhibit PRRSV Replication.

Journal: Microorganisms

Published: October 14, 2025

Screening and Characterization of TAT-Fused Nanobodies Targeting Bovine Viral Diarrhea Virus NS3/NS5A for Antiviral Application.

Screening and Characterization of TAT-Fused Nanobodies Targeting Bovine Viral Diarrhea Virus NS3/NS5A for Antiviral Application.

Journal: Biomolecules

Published: September 12, 2025

Systematic review and meta-analysis on the diagnostic accuracy of various detection methods for porcine reproductive and respiratory syndrome virus.

Systematic review and meta-analysis on the diagnostic accuracy of various detection methods for porcine reproductive and respiratory syndrome virus.

Journal: Porcine health management

Published: July 16, 2025

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Brucella-infected macrophage-derived microparticles enhance the host anti-Brucella acquired immune response.

Journal: Veterinary microbiology

Published: June 14, 2025

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Brucella-infected macrophage-derived Exosomes enhance the anti-Brucella acquired immune response.

Journal: International immunopharmacology

Published: June 13, 2025

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

A BtpB-Deleted Brucella Vaccine Strain Provides Dual Advantages: Enhanced Protection and Diagnostic Differentiation Capability in Mice.

Journal: Microbial biotechnology

Published: June 10, 2025

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice.

PRRSV GP4 subunit vaccine combined with adenovirus heterologous prime-boost immunization strategy induced a significant immune response in mice.

Journal: BMC veterinary research

Published: March 11, 2025

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

A novel IgG-Fc-Fused multiepitope vaccine against Brucella: robust immunogenicity.

Journal: Microbial cell factories

Published: January 22, 2025

Evaluation of the safety and immune protection of OMPAC, PAPF, and EBPSs recombinant subunit vaccines Developed for Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae in mice.

Evaluation of the safety and immune protection of OMPAC, PAPF, and EBPSs recombinant subunit vaccines Developed for Escherichia coli, Staphylococcus aureus, and Streptococcus agalactiae in mice.

Journal: International immunopharmacology

Published: July 12, 2024

Showing 1-12 of 14

Last Updated: 09/26/2026